JP2004143134A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004143134A5 JP2004143134A5 JP2003035096A JP2003035096A JP2004143134A5 JP 2004143134 A5 JP2004143134 A5 JP 2004143134A5 JP 2003035096 A JP2003035096 A JP 2003035096A JP 2003035096 A JP2003035096 A JP 2003035096A JP 2004143134 A5 JP2004143134 A5 JP 2004143134A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- optionally substituted
- compound
- esterified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 description 18
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 8
- 125000000623 heterocyclic group Chemical group 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- 125000001183 hydrocarbyl group Chemical group 0.000 description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- 125000003277 amino group Chemical group 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 125000002252 acyl group Chemical group 0.000 description 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- VDBNYAPERZTOOF-UHFFFAOYSA-N isoquinolin-1(2H)-one Chemical group C1=CC=C2C(=O)NC=CC2=C1 VDBNYAPERZTOOF-UHFFFAOYSA-N 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 3
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 description 1
- 239000012825 JNK inhibitor Substances 0.000 description 1
- 229940118135 JNK inhibitor Drugs 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003035096A JP2004143134A (ja) | 2002-02-13 | 2003-02-13 | Ｊｎｋ阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002035073 | 2002-02-13 | ||
| JP2002251997 | 2002-08-29 | ||
| JP2003035096A JP2004143134A (ja) | 2002-02-13 | 2003-02-13 | Ｊｎｋ阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004143134A JP2004143134A (ja) | 2004-05-20 |
| JP2004143134A5 true JP2004143134A5 (enExample) | 2006-03-23 |
Family
ID=32475121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003035096A Withdrawn JP2004143134A (ja) | 2002-02-13 | 2003-02-13 | Ｊｎｋ阻害剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2004143134A (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR073711A1 (es) * | 2008-10-01 | 2010-11-24 | Astrazeneca Ab | Derivados de isoquinolina |
| EP2947073B1 (en) | 2009-10-22 | 2019-04-03 | Fibrotech Therapeutics Pty Ltd | Fused ring analogues of anti-fibrotic agents |
| EP3290407B1 (en) | 2013-10-18 | 2020-01-01 | Celgene Quanticel Research, Inc | Bromodomain inhibitors |
| EP3194367B1 (en) * | 2014-09-17 | 2021-08-18 | Boehringer Ingelheim International GmbH | Tetrahydroisoquinoline derivatives and pharmaceutical compositions useful for the treatment of obesity and diabetes |
| EP3577103A1 (en) | 2017-02-03 | 2019-12-11 | Certa Therapeutics Pty Ltd. | Anti-fibrotic compounds |
| US20260152484A1 (en) * | 2021-11-09 | 2026-06-04 | Vigil Neuroscience, Inc. | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists |
-
2003
- 2003-02-13 JP JP2003035096A patent/JP2004143134A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008510828A5 (enExample) | ||
| JP2005510476A5 (enExample) | ||
| TW200745029A (en) | Sulfonamide derivatives exhibiting PGD2 receptor antagonism | |
| JP2005503385A5 (enExample) | ||
| WO2004020430A3 (fr) | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique | |
| CA2540163A1 (en) | Thrombin receptor antagonists | |
| WO2008096870A1 (ja) | アザ架橋環化合物 | |
| JP2005536519A5 (enExample) | ||
| JP2010501478A5 (enExample) | ||
| JP2002527414A5 (enExample) | ||
| JP2007519721A5 (enExample) | ||
| WO2007088276A3 (fr) | Derives de sulfonamides, leur preparation et leur application en therapeutique | |
| WO2008126901A1 (ja) | 含窒素複素環化合物およびそれを含有する医薬組成物 | |
| JPWO2023106310A5 (enExample) | ||
| CA2492718A1 (en) | Prodrugs of proton pump inhibitors | |
| WO2009020137A1 (ja) | アミノピラゾールアミド誘導体 | |
| PL378201A1 (pl) | Sposób farmaceutyczny oraz związki wytwarzane tym sposobem | |
| CA2481767A1 (en) | Severe sepsis preventive therapeutic agent | |
| WO2005033066A3 (fr) | Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique sanofi-synthelabo | |
| JP2002522386A5 (enExample) | ||
| JP2005526138A5 (enExample) | ||
| JP2003513066A5 (enExample) | ||
| JP2004502677A5 (enExample) | ||
| JP2006503056A5 (enExample) | ||
| MXPA03010437A (es) | Derivados de 4-(fenil-piperidin-4-iliden-metil)-benzamida y su uso para tratar dolor, ansiedad o transtornos gastrointestinales. |